954 related articles for article (PubMed ID: 36560692)
1. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
Cegolon L; Negro C; Mastrangelo G; Filon FL;
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
[No Abstract] [Full Text] [Related]
2. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
Cegolon L; Magnano G; Negro C; Larese Filon F;
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
[No Abstract] [Full Text] [Related]
3. COVID-19 Incidence and Vaccine Effectiveness in University Staff, 1 March 2020-2 April 2022.
Cegolon L; Negro C; Pesce M; Filon FL
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851360
[No Abstract] [Full Text] [Related]
4. COVID-19 in City Council Civil Servants, 1 March 2020-31 January 2023: Risk of Infection, Reinfection, Vaccine Effectiveness and the Impact of Heterologous Triple Vaccination.
Cegolon L; Larese Filon F
Vaccines (Basel); 2024 Feb; 12(3):. PubMed ID: 38543888
[No Abstract] [Full Text] [Related]
5. SARS-CoV-2 Infection in Health Care Workers of Trieste (North-Eastern Italy), 1 October 2020-7 February 2022: Occupational Risk and the Impact of the Omicron Variant.
Cegolon L; Ronchese F; Ricci F; Negro C; Larese-Filon F
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016284
[TBL] [Abstract][Full Text] [Related]
6. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).
Basso P; Negro C; Cegolon L; Larese Filon F
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215930
[No Abstract] [Full Text] [Related]
7. COVID-19 vaccine effectiveness among healthcare workers: a hospital-based cohort study.
Gaio V; Santos AJ; Amaral P; Faro Viana J; Antunes I; Pacheco V; Paiva A; Pinto Leite P; Antunes Gonçalves L; Araújo L; Silva A; Dias C; Kislaya I; Nunes B; Machado A
BMJ Open; 2023 May; 13(5):e068996. PubMed ID: 37130692
[TBL] [Abstract][Full Text] [Related]
8. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study.
Muhsen K; Maimon N; Mizrahi A; Bodenheimer O; Cohen D; Maimon M; Grotto I; Dagan R
Clin Infect Dis; 2022 Aug; 75(1):e755-e763. PubMed ID: 34698808
[TBL] [Abstract][Full Text] [Related]
10. Test negative case-control study of COVID-19 vaccine effectiveness for symptomatic SARS-CoV-2 infection among healthcare workers: Zambia, 2021-2022.
Mweso O; Simwanza J; Malambo W; Banda D; Fwoloshi S; Sinyange N; Yoo YM; Feldstein LR; Kapina M; Mulenga LB; Liwewe MM; Musonda K; Kapata N; Mwansa FD; Agolory S; Bobo P; Hines J; Chilengi R
BMJ Open; 2023 Dec; 13(12):e072144. PubMed ID: 38072491
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India.
Malhotra S; Mani K; Lodha R; Bakhshi S; Mathur VP; Gupta P; Kedia S; Sankar J; Kumar P; Kumar A; Ahuja V; Sinha S; Guleria R; ; Dua A; Ahmad S; Sathiyamoorthy R; Sharma A; Sakya T; Gaur V; Chaudhary S; Sharma S; Madan D; Gupta A; Virmani S; Gupta A; Yadav N; Sachdeva S; Sharma S; Singh S; Pandey A; Singh M; Jhurani D; Sarkar S; Lokade AK; Mohammad A; Pandit S; Dubey R; Singh AK; Gohar N; Soni D; Bhattacharyya A; Rai S; Tummala S; Gupta I; Shukla S
JAMA Netw Open; 2022 Jan; 5(1):e2142210. PubMed ID: 34994793
[TBL] [Abstract][Full Text] [Related]
12. Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.
Yassi A; Grant JM; Lockhart K; Barker S; Sprague S; Okpani AI; Wong T; Daly P; Henderson W; Lubin S; Kim Sing C
PLoS One; 2021; 16(7):e0254920. PubMed ID: 34270608
[TBL] [Abstract][Full Text] [Related]
13. A Multi-Center Study Investigating Long COVID-19 in Healthcare Workers from North-Eastern Italy: Prevalence, Risk Factors and the Impact of Pre-Existing Humoral Immunity-ORCHESTRA Project.
Cegolon L; Mauro M; Sansone D; Tassinari A; Gobba FM; Modenese A; Casolari L; Liviero F; Pavanello S; Scapellato ML; Taus F; Carta A; Spiteri G; Monaco MGL; Porru S; Larese Filon F
Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140174
[No Abstract] [Full Text] [Related]
14. Effectiveness of MRNA booster vaccine among healthcare workers in New York City during the Omicron surge, December 2021 to January 2022.
Robilotti EV; Whiting K; Lucca A; Poon C; Jani K; McMillen T; Freeswick S; Korenstein D; Babady NE; Seshan VE; Kamboj M
Clin Microbiol Infect; 2022 Dec; 28(12):1624-1628. PubMed ID: 35931373
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts.
Zeng T; Lu Y; Zhao Y; Guo Z; Sun S; Teng Z; Tian M; Wang J; Li S; Fan X; Wang W; Cai Y; Liao G; Liang X; He D; Wang K; Zhao S
Respir Res; 2023 Oct; 24(1):246. PubMed ID: 37828565
[TBL] [Abstract][Full Text] [Related]
16. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of primary series CoronaVac vaccine in preventing COVID-19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May-November 2021.
Katz MA; Rojas Castro MY; Seyidov N; Herdman MT; Mehdiyev S; McKnight CJ; Guseinova A; Cojocaru R; Doran J; Mühlemann B; Drosten C; Suleymanova J; Pebody R; Kissling E; Hagverdiyev G
Influenza Other Respir Viruses; 2023 Oct; 17(10):e13147. PubMed ID: 37799775
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers in Milan (Lombardy Region, Northern Italy).
Consonni D; Lombardi A; Mangioni D; Bono P; Oggioni M; Uceda Renteria S; Valzano A; Bordini L; Nava CD; Tiwana N; Gentiloni Silverj F; Castaldi S; Rognoni M; Cavalieri D'Oro L; Carugno M; Luisetti G; Riboldi L; Ceriotti F; Bandera A; Gori A; Pesatori AC
Epidemiol Prev; 2022; 46(4):250-258. PubMed ID: 36259341
[TBL] [Abstract][Full Text] [Related]
19. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022.
Vicentini M; Venturelli F; Mancuso P; Bisaccia E; Zerbini A; Massari M; Cossarizza A; De Biasi S; Pezzotti P; Bedeschi E; Giorgi Rossi P; ;
Euro Surveill; 2023 Mar; 28(13):. PubMed ID: 36995374
[TBL] [Abstract][Full Text] [Related]
20. Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.
Carazo S; Skowronski DM; Brisson M; Barkati S; Sauvageau C; Brousseau N; Gilca R; Fafard J; Talbot D; Ouakki M; Gilca V; Carignan A; Deceuninck G; De Wals P; De Serres G
Lancet Infect Dis; 2023 Jan; 23(1):45-55. PubMed ID: 36152671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
